Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | FES | P07332 | 1/20 | 0.62 |
| ▸ | RET | P07949 | 1/20 | 0.62 |
| ▸ | MARK3 | P27448 | 1/20 | 0.62 |
| ▸ | TYK2 | P29597 | 1/20 | 0.62 |
| ▸ | FLT4 | P35916 | 1/20 | 0.62 |
| ▸ | SYK | P43405 | 1/20 | 0.62 |
| ▸ | CLK2 | P49760 | 1/20 | 0.62 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL163993 | 1.00 | RECQL (1.00) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL30559826 | 0.87 | RECQL (0.77) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL25779421 | 0.86 | RECQL (0.76) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL1704281 | 0.86 | RECQL (0.75) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL29460250 | 0.85 | FES (0.81) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL9130703 | 0.85 | FES (0.81) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL2424556 | 0.84 | RECQL (0.72) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL10403403 | 0.84 | RECQL (0.72) | RECQLMAPTALDH1A1FESRET | |
| SCHEMBL27823198 | 0.83 | RECQL (0.70) | RECQLSMN1; SMN2L3MBTL1LMNA | |
| SCHEMBL1274303 | 0.83 | RECQL (0.71) | RECQLMAPTALDH1A1FESRET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| EP-4479146-A1 | COSMETIC COMPOSITION | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| CN-119110720-A | Cosmetic composition | 布茨公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118994104-A | Compound serving as PARP-NAMPT double-target inhibitor and application thereof | 天津市医药科学研究所(天津市医药与健康研究中心) | 2024-11-22 | — | — | CN | claimed |
| WO-2023156070-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| CN-115109049-A | Triazine compound containing aryl urea structure and application thereof | 江西科技师范大学 | 2022-09-27 | — | — | CN | claimed |
| US-20250304576-A1 | IKK INHIBITORS | CANCER RESEARCH TECH LTD (GB) | 2025-10-02 | — | — | US | disclosed |
| US-12240862-B2 | Inhibitors of peptidylarginine deiminases | GILEAD SCIENCES, INC. (US) | 2025-03-04 | — | — | US | disclosed |
| CN-119300805-A | Skin care compositions and methods of use | 高露洁-棕榄公司 | 2025-01-10 | — | — | CN | disclosed |
| EP-4479021-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | disclosed |
| CN-119110720-A | Cosmetic composition | 布茨公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-119072299-A | Cosmetic composition containing retinoid, centella asiatica extract and dipeptide | 布茨公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-118994104-A | Compound serving as PARP-NAMPT double-target inhibitor and application thereof | 天津市医药科学研究所(天津市医药与健康研究中心) | 2024-11-22 | — | — | CN | disclosed |
| CN-115109049-B | Triazine compound containing aryl urea structure and application thereof | 江西科技师范大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-115735024-A | Copper electroplating bath | 德国艾托特克有限两合公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-115286617-A | Protac compound for targeted degradation of NAMPT and application thereof | 中国人民解放军海军军医大学 | 2022-11-04 | — | — | CN | disclosed |
| CN-115109049-A | Triazine compound containing aryl urea structure and application thereof | 江西科技师范大学 | 2022-09-27 | — | — | CN | disclosed |
| WO-2022165254-A1 | KITS FOR DERMAL CARE | CHEMISTRYRX (US) | 2022-08-04 | — | — | WO | disclosed |
| CN-108883260-B | Skin care applicator | 宝洁公司 | 2022-04-29 | — | — | CN | disclosed |
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | VALO HEALTH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304576-A1 | IKK INHIBITORS | NFKBIA, IKBKE, IKBKB | RECQL 380/4885MAPT 1448/4885ALDH1A1 4083/4885 |
| US-11279687-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNT, NQO1 | RECQL 2720/4885MAPT 694/4885ALDH1A1 511/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | RECQL 1290/4885MAPT 2895/4885ALDH1A1 2131/4885 |
| US-12240862-B2 | Inhibitors of peptidylarginine deiminases | PADI4, PADI2, PADI1 | RECQL 884/4885MAPT 3578/4885ALDH1A1 2537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.